$LIF

Hulls Chris sold $661K of LIF

Hulls Chris sold 16,379 shares of Life360, Inc. (LIF) at $40.34 ($0.66M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hulls Chris
Published Jun 1, 2026, 9:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LIF
Neutral
medium confidence
Mentioned
$LIF
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFNeutralLow
01

Why it matters

The disclosure provides a new datapoint on insider behavior but does not indicate a new operational or financial development for the company.

02

Market read

Insider selling can influence short-term sentiment, but 10b5-1 plans typically reduce interpretive power.

03

What to watch

Traders may over-weight the headline; the key is whether this sale is unusual relative to prior director activity, which is not provided here.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session disclosure of the 2026-05-28 insider sale

Background

The article is an SEC Form 4 insider transaction disclosure for Life360, Inc. (director Chris Hulls).

Company-level read

Ticker impact

$LIFNeutralMedium confidence
Context

Life360 director Chris Hulls sold 16,379 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low-to-moderate downward bias intraday/near-term if market interprets as bearish, but magnitude likely muted by 10b5-1 context.

Evidence & confidence

The filing is a routine insider sale with a stated pre-arranged 10b5-1 plan; without additional context (e.g., size vs. typical sales, new fundamental news), directional impact is usually limited.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than a change in fundamentals.

Key entities

  • Life360, Inc.

    Company whose shares were sold by a director via an open-market transaction.

  • Chris Hulls

    Director who sold 16,379 shares under a pre-arranged 10b5-1 plan.

Related articles

$BHPMedAI 8/10

Aussie shares lift as weak growth softens rate outlook

Australian shares edged higher after weaker-than-forecast growth data reduced expectations of further Reserve Bank rate hikes. The S&P/ASX200 rose 0.48% to 8,766.2; GDP grew 0.3% in the March quarter (2.5% YoY), below estimates. Mining gained as BHP and Rio Tinto hit record highs on higher copper; energy rose with Brent near $97. Ampol jumped after watchdog approval of its EG Australia acquisition; Maggie Beer surged on a reported up to $10m bid.

$LIFMedAI 9/10

Life360 (LIF) Q1 2026 Earnings Transcript

Life360 reported Q1 2026 revenue of $143.1 million, up 38%, driven by record subscription revenue of $108.2 million (+32%) and a first-time breakout of advertising revenue at $19.7 million (+329%) after the Nativo acquisition. Gross margin fell to 77%. The company raised full-year revenue guidance to $650–$685 million and adjusted EBITDA to $130–$140 million.

$LIFHighAI 9/10

Life360 Raises 2026 Outlook After Record Year, Bets on AI for Family Safety Growth

Life360 (NASDAQ:LIF) reported record 2025 results and raised its 2026 outlook at its annual meeting, where shareholders reelected four directors and approved remaining proposals. The company said 2025 revenue neared $490M (+32%), adjusted EBITDA rose to $93M+ (margin 19%), and operating cash flow was ~$89M. For 2026, it guided revenue to $650M–$685M and adjusted EBITDA to $130M–$140M, and outlined an “agentic AI” plan for family safety growth.